Zydus Hospital has introduced Next-Generation Sequencing (NGS), a molecular tool for detecting genetic mutations linked to ...

Research underscores importance of both genetic and functional testing in diagnosing mitochondrial disorders, particularly ...

Tuberculosis (TB) remains a global health challenge, affecting millions each year. Globally, an estimated 10.8 million people ...

This A-List features two lists of sequencing instrument providers: eight for NGS instruments and three for Sanger ...

Market is expected to grow at 16% by 2029. The high risk of chromosomal abnormalities with rising maternal age, the surge in ...

TB One’ Solution is a pre-sequencing kit that enables the preparation of a ready-to-sequence library from TB DNA.

The test works by looking for cell-free nucleosomes in the blood. The study included 229 patients diagnosed with cancer and ...

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...

HaystackAnalytics unveils ‘TB One’ solution to strengthen India's TB control efforts: Our Bureau, Bengaluru Wednesday, March ...

Gene Solutions, a leading biotech company in Asia, proudly announces a groundbreaking achievement in cancer early detection.

The United States genetic testing market is poised for substantial growth, projected to expand from USD 4.71 billion in 2021 to approximately USD 12.08 billion by 2028, with a robust CAGR of 14.50%.